MiNK Therapeutics, Inc.

NASDAQ:INKT

Biotechnology

Healthcare
$10.22 -2.87%

-$0.35 today

Market cap
$52.17M
Beta
0.47
P/E (TTM)
-4.6
EPS (TTM)
-$2.60
52W Low $6.80High $76.00

Volume 0.01M

Average 0.05M

Price history

MiNK Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-6.03%

Period high

$14.21

Period low

$8.56

Latest

$10.22

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Oct 14, 2026Oct 14, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
8-KAug 13, 2026Aug 13, 2026
S-8Aug 13, 2026Aug 13, 2026
10-QAug 13, 2026Aug 13, 2026
8-KJun 23, 2026Jun 23, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 2, 2026Jun 2, 2026
4Jun 2, 2026Jun 2, 2026
4Jun 2, 2026Jun 2, 2026
4Jun 2, 2026Jun 2, 2026

Competitors

Who does MiNK Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about INKT's filings, answered from its disclosures.

What is the latest INKT filing?

The latest filing shown is 4 dated Oct 14, 2026.

How many recent filings does INKT have?

Intrinsic Alpha currently shows 20 recent filings for INKT.